β-synuclein aggregates and induces neurodegeneration in dopaminergic neurons

Annals of Neurology

Volumn 74, Issue 1, 2013, Pages 109-118

  Taschenberger, Grit ^a   Toloe, Johan ^a   Tereshchenko, Julia ^a   Akerboom, Jasper ^b   Wales, Pauline ^a   Benz, Roland ^c,d   Becker, Stefan ^e   Outeiro, Tiago F ^a   Looger, Loren L ^b   Bähr, Mathias ^a   Zweckstetter, Markus ^e,f   Kügler, Sebastian ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d JACOBS UNIVERSITY BREMEN   (Germany)

^e MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; GAMMA SYNUCLEIN; PROTEINASE K;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DOPAMINERGIC NERVE CELL; ENERGY YIELD; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; SUBSTANTIA NIGRA PARS COMPACTA; VIRUS RECOMBINANT;

ALPHA-SYNUCLEIN; ANIMALS; BETA-SYNUCLEIN; BIOPHYSICAL PROCESSES; CALCIUM; CELLS, CULTURED; DEPENDOVIRUS; DOPAMINERGIC NEURONS; EMBRYO, MAMMALIAN; FEMALE; GAMMA-SYNUCLEIN; GREEN FLUORESCENT PROTEINS; MEMBRANE POTENTIALS; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; MUTATION; NERVE DEGENERATION; RATS; RATS, WISTAR; RESPIRATION; SUBSTANTIA NIGRA; TRANSFECTION; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84883279162     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23905     Document Type: Article

References (37)

1. von Bohlen und Halbach O,. Synucleins and their relationship to Parkinson's disease. Cell Tissue Res 2004; 318: 163-174.
2. Mori F, Tanji K, Yoshimoto M, et al. Immunohistochemical comparison of alpha- and beta-synuclein in adult rat central nervous system. Brain Res 2002; 941: 118-126.
3. Surgucheva I, McMahon B, Surguchov A,. gamma-Synuclein has a dynamic intracellular localization. Cell Motil Cytoskeleton 2006; 63: 447-458.
4. Greten-Harrison B, Polydoro M, Morimoto-Tomita M, et al. αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc Natl Acad Sci U S A 2010; 107: 19573-19578.
5. Jellinger KA,. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012; 27: 8-30.
6. Uversky VN, Li J, Souillac P, et al. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem 2002; 277: 11970-11978.
7. Hashimoto M, Rockenstein E, Mante M, et al. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model. Gene Ther 2004; 11: 1713-1723.
8. Hashimoto M, Rockenstein E, Mante M, et al. beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 2001; 32: 213-223.
9. Fan Y, Limprasert P, Murray IV, et al. Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression. Hum Mol Genet 2006; 15: 3002-3011.
10. Yamin G, Munishkina LA, Karymov MA, et al. Forcing nonamyloidogenic beta-synuclein to fibrillate. Biochemistry 2005; 44: 9096-9107.
11. Vance JM, Ali S, Bradley WG, et al. Gene-environment interactions in Parkinson's disease and other forms of parkinsonism. Neurotoxicology 2010; 31: 598-602.
12. Galvin JE, Uryu K, Lee VM, Trojanowski JQ,. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A 1999; 96: 13450-13455.
13. Fujita M, Sugama S, Sekiyama K, et al. A beta-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain. Nat Commun 2010; 1: 110.
14. Kügler S, Hahnewald R, Garrido M, Reiss J,. Long-term rescue of a lethal inherited disease by adeno-associated virus-mediated gene transfer in a mouse model of molybdenum-cofactor deficiency. Am J Hum Genet 2007; 80: 291-297.
15. Shevtsova Z, Malik I, Garrido M, et al. Potentiation of in vivo neuroprotection by BclX(L) and GDNF co-expression depends on post-lesion time in deafferentiated CNS neurons. Gene Ther 2006; 13: 1569-1578.
16. Taschenberger G, Garrido M, Tereshchenko Y, et al. Aggregation of αsynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons. Acta Neuropathol 2012; 123: 671-683.
17. Kügler S, Meyn L, Holzmuller H, et al. Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors. Mol Cell Neurosci 2001; 17: 78-96.
18. Mironov SL, Skorova E, Hartelt N, et al. Remodelling of the respiratory network in a mouse model of Rett syndrome depends on brain-derived neurotrophic factor regulated slow calcium buffering. J Physiol 2009; 587: 2473-2485.
19. Kim HY, Cho MK, Kumar A, et al. Structural properties of pore-forming oligomers of alpha-synuclein. J Am Chem Soc 2009; 131: 17482-17489.
20. R Foundation for Statistical Computing. 2010. Available at: http://www.R-project.org.
21. Rochet JC, Hay BA, Guo M,. Molecular insights into Parkinson's disease. Prog Mol Biol Transl Sci 2012; 107: 125-188.
22. Correia SC, Santos RX, Perry G, et al. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases. Adv Exp Med Biol 2012; 724: 205-221.
23. Nakamura K, Nemani VM, Azarbal F, et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 2011; 286: 20710-20726.
24. Bueler H,. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease. Apoptosis 2010; 15: 1336-1353.
25. Ninkina N, Peters O, Millership S, et al. Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein. Hum Mol Genet 2009; 18: 1779-1794.
26. Conway KA, Harper JD, Lansbury PT Jr,. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 2000; 39: 2552-2563.
27. Giasson BI, Murray IV, Trojanowski JQ, Lee VM,. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem 2001; 276: 2380-2386.
28. Miake H, Mizusawa H, Iwatsubo T, Hasegawa M,. Biochemical characterization of the core structure of alpha-synuclein filaments. J Biol Chem 2002; 277: 19213-19219.
29. Neumann M, Kahle PJ, Giasson BI, et al. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 2002; 110: 1429-1439.
30. Tsika E, Moysidou M, Guo J, et al. Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration. J Neurosci 2010; 30: 3409-3418.
31. Karpinar DP, Balija MB, Kügler S, et al. Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J 2009; 28: 3256-3268.
32. Schapira AH, Gegg M,. Mitochondrial contribution to Parkinson's disease pathogenesis. Parkinsons Dis 2011; 2011: 159160.
33. Bueler H,. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol 2009; 218: 235-246.
34. Coskun P, Wyrembak J, Schriner SE, et al. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta 2012; 1820: 553-564.
35. Reeve AK, Park TK, Jaros E, et al. Relationship between mitochondria and alpha-synuclein: a study of single substantia nigra neurons. Arch Neurol 2012; 69: 385-393.
36. Tosatto L, Andrighetti AO, Plotegher N, et al. Alpha-synuclein pore forming activity upon membrane association. Biochim Biophys Acta 2012; 1818: 2876-2883.
37. Beyer K, Ispierto L, Latorre P, et al. Alpha- and beta-synuclein expression in Parkinson disease with and without dementia. J Neurol Sci 2011; 310: 112-117.